v3.26.1
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION - (Tables)
 12 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Share Repurchases
The repurchase amounts included in the consolidated financial statements that were related to the 1% excise tax on share repurchases, net of share issuances, as a result of the Inflation Reduction Act of 2022 are (dollars in thousands):
For the twelve months ended
March 31,
20262025
Excise tax payments and accruals included in the consolidated statements of equity:
Acquisition of treasury stock$1,256 $187 
Excise tax payments included in the consolidated statements of cash flows:
Acquisition of treasury stock$128 $58 
Schedule of Stock-based Compensation Activity, by Award Type
The Company's stock-based compensation activity for the twelve months ended March 31, 2026, 2025, and 2024, by award type, was (dollars in thousands):
For the twelve months ended March 31,
202620252024
Stock options$2,091 $3,236 $1,014 
Restricted stock units, time-vesting54,649 82,715 56,583 
Restricted stock units, performance-based16,950 13,359 7,403 
Habu restricted stock awards44 814 144 
Acuity performance plan— — 165 
DataFleets acquisition consideration holdback— — 2,266 
Habu acquisition consideration holdback6,651 4,879 813 
Employee stock purchase plan1,468 1,726 1,666 
Directors stock-based compensation1,135 1,250 1,250 
Total non-cash stock-based compensation included in the consolidated statements of operations82,988 107,979 71,304 
Less expense related to liability-based equity awards(6,688)(4,948)(3,247)
Total non-cash stock-based compensation included in the consolidated statements of equity$76,300 $103,031 $68,057 
Schedule of Effect of Stock-based Compensation Expense on Income, by Financial Statement Line Item
The effect of stock-based compensation expense on income, by financial statement line item, was (dollars in thousands):
For the twelve months ended March 31,
202620252024
Cost of revenue$4,917 $6,165 $3,553 
Research and development25,562 41,704 27,189 
Sales and marketing22,920 27,470 18,948 
General and administrative29,589 32,640 21,614 
Total non-cash stock-based compensation included in the consolidated statements of operations$82,988 $107,979 $71,304 
Schedule of Share-based Compensation Arrangement by Share Based Payment Award, Future Expense
The following table provides the expected future expense for all of the Company's outstanding equity awards at March 31, 2026, by award type (dollars in thousands).
For the twelve months ended March 31,
202720282029Total
Stock options$1,023 $95 $— $1,118 
Restricted stock units50,941 28,033 4,436 83,410 
Habu restricted stock awards6 — — 6 
Habu acquisition consideration holdback2,296 — — 2,296 
Employee stock purchase plan251 — — 251 
Expected future expense$54,517 $28,128 $4,436 $87,081 
Schedule of Option Activity
Stock option activity for the twelve months ended March 31, 2026 was:  
Weighted average
Weighted averageremainingAggregate
Number ofexercise pricecontractual termIntrinsic value
sharesper share(In years)(In thousands)
Outstanding at March 31, 2025370,596 $13.20 
Exercised(268,518)$14.54 $3,948 
Forfeited or canceled(11,468)$9.61 
Outstanding at March 31, 202690,610 $9.69 6.6$1,525 
Exercisable at March 31, 202652,024 $9.76 6.2$872 
Schedule of Stock Options Outstanding and Exercisable
A summary of stock options outstanding and exercisable as of March 31, 2026 was:
Options outstandingOptions exercisable
Range ofWeighted averageWeighted averageWeighted average
exercise priceOptionsremainingexercise priceOptionsexercise price
per shareoutstandingcontractual lifeper shareexercisableper share
$1.20 —$9.99 88,900 6.7 years$9.47 50,314 $9.36 
$20.00 —$24.99 1,710 0.3 years$21.32 1,710 $21.32 
90,610 6.6 years$9.69 52,024 $9.76 
Schedule of Changes in Restricted Stock
Restricted stock share activity for the twelve months ended March 31, 2026 was:

Weighted average
fair value perWeighted average
Numbershare at grantremaining contractual
of sharesdateterm (in years)
Unvested restricted stock awards at March 31, 20251,568 $39.48 
Vested(1,408)$39.48 
Unvested restricted stock awards at March 31, 2026160 $39.48 0.3
Schedule of Time-vesting Restricted Stock Unit Activity
RSU activity for the twelve months ended March 31, 2026 was:
Weighted-average
fair value perWeighted-average
Numbershare at grantremaining contractual
of sharesdateterm (in years)
Outstanding at March 31, 20252,985,522 $32.27 1.76
Granted2,201,909 $29.31 
Vested(1,831,969)$32.01 
Forfeited or canceled(434,320)$31.22 
Outstanding at March 31, 20262,921,142 $30.36 1.89
Schedule of Non-vested Performance-based Restricted Stock Units Activity
PSU activity for the twelve months ended March 31, 2026 was:
Weighted-average
fair value perWeighted-average
Numbershare at grantremaining contractual
of sharesdateterm (in years)
Outstanding at March 31, 20251,395,426 $31.36 1.13
Granted520,826 $33.07 
Vested(332,745)$25.87 
Forfeited or canceled(138,432)$29.42 
Outstanding at March 31, 20261,445,075 $33.43 1.06